转移性脑肿瘤手术患者术前癫痫发作及癫痫控制丧失的危险因素
回顾性分析1998至2011年单中心565例接受转移性脑肿瘤切除术的成人患者,114例(20.2%)术前有癫痫发作;术前癫痫发作、颞叶位置、术后未化疗、肿瘤次全切除及局部复发与术后癫痫控制丧失独立相关;末次随访时93.8%患者无癫痫发作。
要点
- 565例中114例(20.2%)术前出现癫痫发作。
- 术前癫痫发作、颞叶位置、术后未化疗、次全切除、局部复发与术后癫痫控制丧失独立相关。
- 末次随访93.8%患者无癫痫发作,仅8例(1.41%)术前无癫痫者术后新发癫痫。
核心结论
- 术前癫痫发作及术后癫痫控制丧失的相关因素识别可能有助于转移性脑肿瘤患者的管理策略。
- 术前有癫痫发作并接受切除术的患者术后癫痫控制趋向良好。
研究设计与样本
- 回顾性分析单中心1998至2011年接受一个或多个脑转移灶切除术的成人患者。
- 共纳入565例患者。
主要发现
- 565例中114例(20.2%)术前出现癫痫发作。
- 与术前癫痫发作独立相关的因素包括术前头痛(P = 0.044)、认知障碍(P = 0.031)、颅内转移瘤超过2个(P = 0.013)、颞叶位置(P = 0.031)、枕叶位置(P = 0.010)及肿瘤累及骨(P = 0.029)。
- 与手术切除后癫痫控制丧失独立相关的因素包括术前癫痫发作(P = 0.001)、颞叶位置(P = 0.037)、术后未化疗(P = 0.010)、肿瘤次全切除(P = 0.022)及局部复发(P = 0.027)。
- 末次随访时大多数患者(93.8%)无癫痫发作,共30例(5.30%)出现癫痫控制丧失,仅8例(1.41%)术前无癫痫的患者在转移灶手术切除后出现新发癫痫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Metastatic brain tumors are the most common brain tumors in adults. Patients with metastatic brain tumors have poor prognoses with median survival of 6-12 months. Seizures are a major presenting symptom and cause of morbidity and mortality. In this article, risk factors for the onset of preoperative seizures and postoperative seizure control are examined. METHODS: Adult patients who underwent resection of one or more brain metastases at a single institution between 1998 and 2011 were reviewed retrospectively. RESULTS: Of 565 patients, 114 (20.2%) patients presented with seizures. Factors independently associated with preoperative seizures were preoperative headaches (P = 0.044), cognitive deficits (P = 0.031), more than 2 intracranial metastatic tumors (P = 0.013), temporal lobe location (P = 0.031), occipital lobe location (P = 0.010), and bone involvement by tumor (P = 0.029). Factors independently associated with loss of seizure control after surgical resection were preoperative seizures (P = 0.001), temporal lobe location (P = 0.037), lack of postoperative chemotherapy (P = 0.010), subtotal resection of tumor (P = 0.022), and local recurrence (P = 0.027). At last follow-up, the majority of patients (93.8%) were seizure-free. Thirty patients (5.30%) in total had loss of seizure control, and only 8 patients (1.41%) who did not have preoperative seizures presented with new-onset seizures after surgical resection of their metastases. CONCLUSIONS: The brain is a common site for metastases from numerous primary cancers, such as breast and lung. The identification of factors associated with onset of preoperative seizures as well as seizure control postoperatively could aid management strategies for patients with metastatic brain tumors. Patients with preoperative seizures who underwent resection tended to have good seizure control after surgery.
引用
- Wu A, Weingart JD, Gallia GL, et al. Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors. World Neurosurg. 2017. PMID: 28512046. doi:10.1016/j.wneu.2017.05.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。